261 related articles for article (PubMed ID: 24369747)
1. In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
Kilicarslan M; Koerber M; Bodmeier R
Drug Dev Ind Pharm; 2014 May; 40(5):619-24. PubMed ID: 24369747
[TBL] [Abstract][Full Text] [Related]
2. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
Kranz H; Bodmeier R
Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
[TBL] [Abstract][Full Text] [Related]
3. In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance.
Do MP; Neut C; Metz H; Delcourt E; Mäder K; Siepmann J; Siepmann F
Int J Pharm; 2015; 486(1-2):38-51. PubMed ID: 25791762
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo investigation of drug-eluting implants for the treatment of periodontal disease.
Lee FY; Chen DW; Hu CC; Hsieh YT; Liu SJ; Chan EC
AAPS PharmSciTech; 2011 Dec; 12(4):1110-5. PubMed ID: 21879391
[TBL] [Abstract][Full Text] [Related]
5. Effect of zein on biodegradable inserts for the delivery of tetracycline within periodontal pockets.
de Sousa FO; Blanco-Méndez J; Pérez-Estévez A; Seoane-Prado R; Luzardo-Álvarez A
J Biomater Appl; 2012 Aug; 27(2):187-200. PubMed ID: 21586598
[TBL] [Abstract][Full Text] [Related]
6. Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol.
Ahmed TA; Ibrahim HM; Ibrahim F; Samy AM; Kaseem A; Nutan MT; Hussain MD
J Pharm Sci; 2012 Oct; 101(10):3753-62. PubMed ID: 22753324
[TBL] [Abstract][Full Text] [Related]
7. Metronidazole and Pentoxifylline films for the local treatment of chronic periodontal pockets: preparation, in vitro evaluation and clinical assessment.
Labib GS; Aldawsari HM; Badr-Eldin SM
Expert Opin Drug Deliv; 2014 Jun; 11(6):855-65. PubMed ID: 24641528
[TBL] [Abstract][Full Text] [Related]
8. In situ micro-sized gel-forming injectable implant using biodegradable amphiphilic graft copolymer.
Cho KY; Lee S; Park JK
Macromol Biosci; 2007 Jun; 7(6):784-8. PubMed ID: 17541923
[TBL] [Abstract][Full Text] [Related]
9. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
Kranz H; Bodmeier R
Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic analysis of PLGA/HPMC-based in-situ forming implants for periodontitis treatment.
Do MP; Neut C; Metz H; Delcourt E; Siepmann J; Mäder K; Siepmann F
Eur J Pharm Biopharm; 2015 Aug; 94():273-83. PubMed ID: 26047797
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability.
Ahmed TA; Ibrahim HM; Samy AM; Kaseem A; Nutan MT; Hussain MD
AAPS PharmSciTech; 2014 Jun; 15(3):772-80. PubMed ID: 24648158
[TBL] [Abstract][Full Text] [Related]
12. Physical key properties of antibiotic-free, PLGA/HPMC-based in-situ forming implants for local periodontitis treatment.
Agossa K; Lizambard M; Rongthong T; Delcourt-Debruyne E; Siepmann J; Siepmann F
Int J Pharm; 2017 Apr; 521(1-2):282-293. PubMed ID: 28223246
[TBL] [Abstract][Full Text] [Related]
13. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease.
Yue IC; Poff J; Cortés ME; Sinisterra RD; Faris CB; Hildgen P; Langer R; Shastri VP
Biomaterials; 2004 Aug; 25(17):3743-50. PubMed ID: 15020150
[TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis.
Gad HA; El-Nabarawi MA; Abd El-Hady SS
AAPS PharmSciTech; 2008; 9(3):878-84. PubMed ID: 18654864
[TBL] [Abstract][Full Text] [Related]
15. Studies on development of controlled delivery of combination drug(s) to periodontal pocket.
Tiwari G; Tiwari R; Rai AK
Indian J Dent Res; 2010; 21(1):72-83. PubMed ID: 20427912
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive in vivo characterization of microclimate pH inside in situ forming PLGA implants using multispectral fluorescence imaging.
Schädlich A; Kempe S; Mäder K
J Control Release; 2014 Apr; 179():52-62. PubMed ID: 24503251
[TBL] [Abstract][Full Text] [Related]
17. Review: approaches to develop PLGA based in situ gelling system with low initial burst.
Ahmed T
Pak J Pharm Sci; 2015 Mar; 28(2):657-65. PubMed ID: 25730797
[TBL] [Abstract][Full Text] [Related]
18. Metronidazole-loaded bioabsorbable films as local antibacterial treatment of infected periodontal pockets.
Shifrovitch Y; Binderman I; Bahar H; Berdicevsky I; Zilberman M
J Periodontol; 2009 Feb; 80(2):330-7. PubMed ID: 19186975
[TBL] [Abstract][Full Text] [Related]
19. The role of controlled drug delivery for periodontitis. The Research, Science and Therapy Committee of the American Academy of Periodontology.
Greenstein G; Tonetti M
J Periodontol; 2000 Jan; 71(1):125-40. PubMed ID: 10695948
[No Abstract] [Full Text] [Related]
20. Effect of ethylcellulose and propylene glycol on the controlled-release performance of glyceryl monooleate-mertronidazole periodontal gel.
Sallam AS; Hamudi FF; Khalil EA
Pharm Dev Technol; 2015 Mar; 20(2):159-68. PubMed ID: 24262092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
